drugset / Trial / NCT05631990
A Study to Evaluate the Efficacy and Safety of AD-209
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of AD-209
Timeline
- Start
- 2023-04-05
- Primary completion
- 2023-11-27
- Completion
- 2023-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-209-1A | Unknown | — | Oral |
| Subject | AD-209-1B | Unknown | — | Oral |
| Subject | AD-209-1C | Unknown | — | Oral |
| Subject | AD209 | Unknown | — | Oral |